Visual hallucinations in Parkinson's disease: Clues to separate origins
暂无分享,去创建一个
G. Albani | M. Onofrj | A. Thomas | L. Bonanni | Astrid Thomas | A. Mauro | G. Albani | A. Mauro | L. Bonanni | A. Thomas | M. Onofrj | A. Mauro | D. Bulla | D. Bulla
[1] Enrico Marchioni,et al. Relationship between hallucinations, delusions, and rapid eye movement sleep behavior disorder in Parkinson's disease , 2005, Movement disorders : official journal of the Movement Disorder Society.
[2] David R Williams,et al. Visual hallucinations in the diagnosis of idiopathic Parkinson's disease: a retrospective autopsy study , 2005, The Lancet Neurology.
[3] S. Papapetropoulos,et al. Factors associated with drug–induced visual hallucinations in Parkinson's disease , 2005, Journal of Neurology.
[4] M. Oda,et al. The Relation Between Visual Hallucinations and Visual Evoked Potential in Parkinson Disease , 2005, Clinical neuropharmacology.
[5] G. Fénelon,et al. Hallucinations in Parkinson's disease: A follow‐up study , 2005, Movement disorders : official journal of the Movement Disorder Society.
[6] G. Stebbins,et al. Repeated visual hallucinations in Parkinson's disease as disturbed external/internal perceptions: Focused review and a new integrative model , 2005, Movement disorders : official journal of the Movement Disorder Society.
[7] C. Peretz,et al. Antiparkinsonian medication is not a risk factor for the development of hallucinations in Parkinson’s disease , 2004, Journal of Neural Transmission.
[8] M. Boggild,et al. Charles Bonnet syndrome—elderly people and visual hallucinations , 2004, BMJ : British Medical Journal.
[9] D. Calne,et al. Presynaptic mechanisms of motor fluctuations in Parkinson's disease: a probabilistic model. , 2004, Brain : a journal of neurology.
[10] M. Onofrj,et al. Severe worsening of parkinsonism in Lewy body dementia due to donepezil , 2003, Neurology.
[11] A. Destée,et al. Retinal involvement in dementia with Lewy bodies: A clue to hallucinations? , 2003, Annals of neurology.
[12] W. Poewe. Psychosis in Parkinson's disease , 2003, Movement disorders : official journal of the Movement Disorder Society.
[13] G. Ebersbach. An artist's view of drug‐induced hallucinosis , 2003, Movement disorders : official journal of the Movement Disorder Society.
[14] Yuichi Inoue,et al. Visual hallucinations as REM sleep behavior disorders in patients with Parkinson's disease , 2003, Movement disorders : official journal of the Movement Disorder Society.
[15] M. Onofrj,et al. HLA typing does not predict REM sleep behaviour disorder and hallucinations in Parkinson's disease , 2003, Movement disorders : official journal of the Movement Disorder Society.
[16] M. Onofrj,et al. Mirtazapine induces REM sleep behavior disorder (RBD) in parkinsonism , 2003, Neurology.
[17] M. Rossor,et al. “—but who is that on the other side of you?” Extracampine hallucinations revisited , 2002, The Lancet.
[18] W. Burke,et al. The neural basis of Charles Bonnet hallucinations: a hypothesis , 2002, Journal of neurology, neurosurgery, and psychiatry.
[19] M. Onofrj,et al. Incidence of RBD and hallucination in patients affected by Parkinson's disease: 8-year follow-up , 2002, Neurological Sciences.
[20] A. Korczyn. Hallucinations in Parkinson's disease , 2001, The Lancet.
[21] F. Provini,et al. Agrypnia excitata: clinical features and pathophysiological implications. , 2001, Sleep medicine reviews.
[22] A. David,et al. Visual hallucinations in Parkinson's disease: a review and phenomenological survey , 2001, Journal of neurology, neurosurgery, and psychiatry.
[23] D. Joel,et al. Open interconnected model of basal ganglia‐thalamocortical circuitry and its relevance to the clinical syndrome of Huntington's disease , 2001, Movement disorders : official journal of the Movement Disorder Society.
[24] A. Husain,et al. REM Sleep Behavior Disorder: Potential Relationship to Post-traumatic Stress Disorder , 2001, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.
[25] R. Stickgold,et al. Dreaming and the brain: Toward a cognitive neuroscience of conscious states , 2000, Behavioral and Brain Sciences.
[26] Y. Agid,et al. Hallucinations, REM sleep, and Parkinson’s disease , 2000, Neurology.
[27] G. Fénelon,et al. Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors. , 2000, Brain : a journal of neurology.
[28] R. Raman,et al. Decreased color discrimination and contrast sensitivity in Parkinson’s disease , 2000, Journal of the Neurological Sciences.
[29] I. Anjegård,et al. [Two cases of peduncular hallucinosis. Vivid, colorful and dancing images and figures]. , 1999, Lakartidningen.
[30] S. Leurgans,et al. Hallucinations, sleep fragmentation, and altered dream phenomena in Parkinson's disease , 1999, Movement disorders : official journal of the Movement Disorder Society.
[31] S. Leurgans,et al. Poor visual discrimination and visual hallucinations in Parkinson's disease. , 1998, Clinical neuropharmacology.
[32] Y. Inoue,et al. Night‐time hypnopompic visual hallucinations related to REM sleep disorder , 1998, Psychiatry and clinical neurosciences.
[33] R. Grünewald,et al. Hallucinosis in idiopathic Parkinson’s disease , 1997, Journal of neurology, neurosurgery, and psychiatry.
[34] Karl J. Friston,et al. Dopaminergic modulation of impaired cognitive activation in the anterior cingulate cortex in schizophrenia , 1995, Nature.
[35] R. Teunisse,et al. The Charles Bonnet Syndrome: A Large Prospective Study in the Netherlands , 1995, British Journal of Psychiatry.
[36] R. de la Fuente Fernández,et al. Peduncular hallucinosis and right hemiparkinsonism caused by left mesencephalic infarction. , 1994, Journal of neurology, neurosurgery, and psychiatry.
[37] C. Tanner,et al. Polysomnographic sleep measures in Parkinson's disease patients with treatment‐induced hallucinations , 1993, Annals of neurology.
[38] R. Melzack,et al. Visual Hallucinations and Mental State: A Study of 14 Charles Bonnet Syndrome Hallucinators , 1993, The Journal of nervous and mental disease.
[39] M. Onofrj,et al. Narcolepsy associated with primary temporal lobe B-cells lymphoma in a HLA DR2 negative subject. , 1992, Journal of neurology, neurosurgery, and psychiatry.
[40] T. Di Paolo,et al. Decreased dopamine in the retinas of patients with Parkinson's disease. , 1990, Investigative ophthalmology & visual science.
[41] D. Levine,et al. Peduncular hallucinosis associated with isolated infarction of the substantia nigra pars reticulata , 1990, Annals of neurology.
[42] J. Saint-Cyr,et al. Procedural learning and neostriatal dysfunction in man. , 1988, Brain : a journal of neurology.
[43] M. Ghilardi,et al. Spatial frequency-dependent abnormalities of the pattern electroretinogram and visual evoked potentials in a parkinsonian monkey model. , 1988, Brain : a journal of neurology.
[44] N. Swerdlow,et al. Dopamine, schizophrenia, mania, and depression: Toward a unified hypothesis of cortico-striatopallido-thalamic function , 1987, Behavioral and Brain Sciences.
[45] M. Ghilardi,et al. Visual evoked potentials in parkinsonism and dopamine blockade reveal a stimulus-dependent dopamine function in humans. , 1986, Journal of neurology, neurosurgery, and psychiatry.
[46] M W Mahowald,et al. Chronic behavioral disorders of human REM sleep: a new category of parasomnia. , 1986, Sleep.
[47] M. Onofrj,et al. Dopaminergic deficiency causes delayed visual evoked potentials in rats , 1982, Annals of neurology.
[48] C. Goetz,et al. Pharmacology of hallucinations induced by long-term drug therapy. , 1982, The American journal of psychiatry.
[49] M. Onofrj,et al. SYSTEM DISEASES AND VISUAL EVOKED POTENTIAL DIAGNOSIS IN NEUROLOGY: CHANGES DUE TO SYNAPTIC MALFUNCTION * , 1980, Annals of the New York Academy of Sciences.
[50] M. Yahr,et al. Measurements of visual evoked potentials in Parkinson's disease. , 1978, Brain : a journal of neurology.
[51] H. Klawans,et al. Levodopa-induced psychosis: a kindling phenomenon. , 1978, The American journal of psychiatry.
[52] J. Feigenson,et al. Mental symptoms in Parkinson's disease during chronic treatment with levodopa , 1976, Neurology.
[53] S. Folstein,et al. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.
[54] R. Harper,et al. Coloured Lilliputian Hallucinations with Amantadine , 1973, The Medical journal of Australia.
[55] O. Sacks,et al. Effects of levodopa in parkinsonian patients with dementia , 1972, Neurology.
[56] A. Damasio,et al. Psychiatric aspects in Parkinsonism treated with L-dopa , 1971, Journal of neurology, neurosurgery, and psychiatry.
[57] G. Celesia,et al. Psychosis and other psychiatric manifestations of levodopa therapy. , 1970, Archives of neurology.
[58] D. Ross,et al. Mental Symptoms in Parkinsonism following Benzhexol Hydrochloride Therapy , 1956, British medical journal.
[59] W. Kuhn,et al. Effects of apomorphine on visual functions in Parkinson's disease , 2000, Journal of Neural Transmission.
[60] M. Tagliati,et al. The visual system in Parkinson's disease. , 1993, Advances in neurology.
[61] M. Mahowald,et al. Status dissociatus--a perspective on states of being. , 1991, Sleep.
[62] W. Weiner,et al. Sleep disorders and sleep effect in Parkinson's disease , 1990, Movement disorders : official journal of the Movement Disorder Society.
[63] M. Ghilardi,et al. Systemic 1-methyl,4-phenyl,1-2-3-6-tetrahydropyridine (MPTP) administration decreases retinal dopamine content in primates. , 1988, Life sciences.
[64] S. Fahn. Unified Parkinson's Disease Rating Scale , 1987 .
[65] C. Marsden,et al. Recent Developments in Parkinson's Disease , 1986 .
[66] P. Rondot,et al. Mental disorders in Parkinson's disease after treatment with L-DOPA. , 1984, Advances in neurology.